<div id="readability-page-1"><p>Shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH - Get Free Report) have been assigned a consensus recommendation of &#34;Hold&#34; from the ten research firms that are  covering the stock, Marketbeat Ratings reports. Six analysts have rated the stock with a hold recommendation and four have given a buy recommendation to  the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $10.1875.</p><p>A number of analysts recently issued reports on the company. UBS Group raised their price target on Aveanna Healthcare from $9.00 to $9.50 and gave the stock a &#34;neutral&#34; rating in a research report on Friday, November 7th. Royal Bank Of Canada lifted their price target on shares of Aveanna Healthcare from $8.00 to $10.00 and gave the stock a &#34;sector perform&#34; rating in a research note on Friday, October 24th. Barclays upgraded shares of Aveanna Healthcare from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and upped their price target for the company from $5.50 to $9.50 in a report on Tuesday, August 19th. JPMorgan Chase &amp; Co. raised Aveanna Healthcare from an &#34;underweight&#34; rating to a &#34;neutral&#34; rating and upped their target price for the company from $6.00 to $10.00 in a research note on Thursday, September 18th. Finally, BMO Capital Markets began coverage on Aveanna Healthcare in a research report on Thursday, November 13th. They set an &#34;outperform&#34; rating and a $11.00 target price for the company.</p><div><p><span></span><span>Get <strong>Aveanna Healthcare</strong> alerts:</span></p></div><p><b>Check Out Our Latest Stock Report on AVAH</b></p><h2>Insider Buying and Selling</h2><p>In other news, major shareholder J.H. Whitney Equity Partners V sold 8,346,059 shares of the business's stock in a transaction dated Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total value of $75,114,531.00. Following the completion of the sale, the insider owned 20,544,696 shares in the company, valued at approximately $184,902,264. The trade was a 28.89% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, major shareholder Paul R. Vigano sold 10,000,000 shares of Aveanna Healthcare stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $9.00, for a total transaction of $90,000,000.00. Following the transaction, the insider directly owned 386,284 shares in the company, valued at approximately $3,476,556. The trade was a 96.28% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,597,968 shares of company stock valued at $293,381,712 over the last quarter. 7.80% of the stock is owned by corporate insiders. </p><h2>Institutional Inflows and Outflows</h2><p>A number of institutional investors and hedge funds have recently modified their holdings of the company. Summit Partners L P acquired a new stake in  Aveanna Healthcare in the second quarter worth about $50,477,000.  AustralianSuper Pty Ltd acquired a new stake in shares of  Aveanna Healthcare during the third quarter worth about $15,743,000.  Vanguard Group Inc. increased its stake in shares of  Aveanna Healthcare by 34.7% in the third quarter. Vanguard Group Inc. now owns 4,041,659 shares of the company's stock worth $35,850,000 after acquiring an additional 1,041,324 shares during the period.  Hillsdale Investment Management Inc. acquired a new stake in  Aveanna Healthcare during the 3rd quarter worth about $7,922,000.  Finally, Assenagon Asset Management S.A. purchased a new stake in shares of  Aveanna Healthcare in the third quarter worth about $7,356,000. Hedge funds and other institutional investors own  87.96% of the company's stock. </p><h2>Aveanna Healthcare Stock Performance</h2><p>Shares of NASDAQ:AVAH opened at $9.32 on Friday. The firm has a fifty day simple moving average of $9.03 and a two-hundred day simple moving average of $6.90. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 140.39. The stock has a market capitalization of $1.95 billion, a P/E ratio of 25.88 and a beta of 2.04. Aveanna Healthcare has a 52 week low of $3.67 and a 52 week high of $10.32. </p><p>Aveanna Healthcare (NASDAQ:AVAH - Get Free Report) last announced its quarterly earnings results on Monday, May 22nd. The company reported $0.04 EPS for the quarter. The firm had revenue of $450.53 million during the quarter. Aveanna Healthcare had a net margin of 3.29% and a negative return on equity of 143.55%.  On average, analysts expect that  Aveanna Healthcare will post -0.06 earnings per share for the current fiscal year. </p><h2>Aveanna Healthcare Company Profile</h2> (Get Free Report)<p>Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Aveanna Healthcare</li><li>What is a Stock Market Index and How Do You Use Them?</li><li>Power On: Applied Digital’s First AI Data Center Goes Live</li><li>Do ETFs Pay Dividends? What You Need to Know</li><li>Alphabet: The AI Leader Best Positioned to Dominate 2026</li><li>3 Defense Stocks Set to Benefit From Increased Military Spending</li><li>2 Reasons to Load Up on Fiserv, 1 to Stay Away</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QVZBSA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Aveanna Healthcare Right Now?</h2><p>Before you consider Aveanna Healthcare, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aveanna Healthcare wasn't on the list.</p><p>While Aveanna Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

AVAH

<p>Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) has received a consensus "Hold" rating from ten research firms. Analysts have set an average 12-month price target of $10.1875. Recent analyst actions include UBS Group raising its price target to $9.50, Royal Bank of Canada to $10.00, Barclays upgrading to "overweight" with a $9.50 target, and JPMorgan Chase & Co. upgrading to "neutral" with a $10.00 target. Insider sales and institutional investments have also been noted, with significant stock transactions by major shareholders.</p>

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Receives Average Rating of "Hold" from Analysts